Clinical Leader’s Post

View organization page for Clinical Leader, graphic

13,130 followers

Preclinical and clinical stage biotechs have been the most impacted but also stand to gain the most after the economic downturn and subsequent recovery. 💰📈 Here, Justin Culbertson, CPA of RSM US LLP delves into how small to midsize pre-revenue biotechs have been specifically impacted and what this could mean for organizations that support them. #clinicaltrials #clinicalresearch #biotech

Cautious Optimism For Biotechs And Their Outsourcing Partners

Cautious Optimism For Biotechs And Their Outsourcing Partners

clinicalleader.com

To view or add a comment, sign in

Explore topics